Volume 21, Number 9—September 2015
Emerging Infections Program
Twenty Years of Active Bacterial Core Surveillance
- Centers for Disease Control and Prevention. Preventing emerging infectious diseases: a strategy for the 21st century. MMWR Recomm Rep. 1998;47(RR-15):1–14 .
- Pinner RW, Rebmann CA, Schuchat A, Hughes JM. Disease surveillance and the academic, clinical, and public health communities. Emerg Infect Dis. 2003;9:781–7.
- Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005;352:1436–44.
- Centers for Disease Control and Prevention. Legionellosis—United States, 2000–2009. MMWR Morb Mortal Wkly Rep. 2011;60:1083–6 .
- American Academy of Pediatrics. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn: Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. Pediatrics. 1992;90:775–8 .
- American Congress of Obstetricians and Gynecologists. Group B streptococcal infections in pregnancy. ACOG Technical Bulletin Number 170–July 1992. Int J Gynaecol Obstet. 1993;42:55–9 .
- Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease: a public health perspective. MMWR Recomm Rep. 1996;45(RR-7):1–24 .
- Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med. 2002;347:233–9.
- Schrag SJ, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. MMWR Recomm Rep. 2002;51(RR-11):1–22.
- Centers for Disease Control and Prevention. Prevention of perinatal group B streptococcal disease–revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1–36.
- Robinson KA, Rothrock G, Phan Q, Sayler B, Stefonek K, Van Beneden C, Risk for severe group A streptococcal disease among patients' household contacts. Emerg Infect Dis. 2003;9:443–7.
- Chuang I, Van Beneden C, Beall B, Schuchat A. Population-based surveillance for postpartum invasive group A Streptococcus infections, 1995–2000. Clin Infect Dis. 2002;35:665–70.
- Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis. 2002;35:950–9.
- Jordan HT, Richards CL Jr, Burton DC, Thigpen MC, Van Beneden CA. Group A streptococcal disease in long-term care facilities: descriptive epidemiology and potential control measures. Clin Infect Dis. 2007;45:742–52.
- Thigpen MC, Richards CL Jr, Lynfield R, Barrett NL, Harrison LH, Arnold KE, Invasive group A streptococcal infection in older adults in long-term care facilities and the community, United States, 1998–2003. Emerg Infect Dis. 2007;13:1852–9.
- Klevens RM, Morrison MA, Nadle J, Petit S, Gershman K, Ray S, Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA. 2007;298:1763–71.
- Centers for Disease Control and Prevention. Management of multidrug-resistant organisms in healthcare settings. 2006 [cited 2013 Nov 4]. http://www.cdc.gov/hicpac/pdf/guidelines/MDROGuideline2006.pdf
- Association for Professionals in Infection Control and Epidemiology. . Guide to the elimination of Methicillin-Resistant Staphylococcus aureus (MRSA) Transmission in Hospital Settings. 2011. [cited 2014 Feb 10]. http://apic.org/Resource_/EliminationGuideForm/16c7a44f-55fe-4c7b-819a-b9c5907eca72/File/APIC-MRSA-California.pdf 2009
- Health and Human Services. National action plan to prevent health care-associated infections: road map to elimination. 2014 [cited 2014 Feb 10]. http://www.health.gov/hai/prevent_hai.asp#hai_plan
- Dantes R, Mu Y, Belflower R, Aragon D, Dumyati G, Harrison LH, National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med. 2013;173:1970–8 .
- Whitney CG, Farley MM, Hadler J, Harrison LH, Lexau C, Reingold A, Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med. 2000;343:1917–24.
- Hampton LM, Farley MM, Schaffner W, Thomas A, Reingold A, Harrison LH, Prevention of antibiotic-nonsusceptible Streptococcus pneumoniae with conjugate vaccines. J Infect Dis. 2012;205:401–11 .
- Dahesh S, Hensler ME, Van Sorge NM, Gertz RE Jr, Schrag S, Nizet V, Point mutation in the group B streptococcal pbp2x gene conferring decreased susceptibility to beta-lactam antibiotics. Antimicrob Agents Chemother. 2008;52:2915–8.
- Park C, Nichols M, Schrag SJ. Two cases of invasive vancomycin-resistant group B Streptococcus infection. N Engl J Med. 2014;370:885–6.
- Centers for Disease Control and Prevention. Emergence of fluoroquinolone-resistant Neisseria meningitides—Minnesota and North Dakota, 2007–2008. MMWR Morb Mortal Wkly Rep. 2008;57:173–5 .
- Rosenstein NE, Stocker SA, Popovic T, Tenover FC, Perkins BA. Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. Clin Infect Dis. 2000;30:212–3.
- Bilukha OO, Rosenstein N. Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2005;54(RR-7):1–21 .
- Begier EM, Barrett NL, Mshar PA, Johnson DG, Hadler JL. Gram-positive rod surveillance for early anthrax detection. Emerg Infect Dis. 2005;11:1483–6.
- Louie JK, Hacker JK, Mark J, Gavali SS, Yagi S, Espinosa A, SARS and common viral infections. Emerg Infect Dis. 2004;10:1143–6.
- Nelson GE, Gershman KA, Swerdlow DL, Beall BW, Moore MR. Invasive pneumococcal disease and pandemic (H1N1) 2009, Denver, Colorado, USA. Emerg Infect Dis. 2012;18:208–16.
- Kainer MA, Reagan DR, Nguyen DB, Wiese AD, Wise ME, Ward J, Fungal infections associated with contaminated methylprednisolone in Tennessee. N Engl J Med. 2012;367:2194–203.
- Hampton LM, Zell ER, Schrag S, Cohen AL. Sentinel versus population-based surveillance of pneumococcal conjugate vaccine effectiveness. Bull World Health Organ. 2012;90:568–77.
- Van Beneden CA, Lexau C, Baughman W, Barnes B, Bennett N, Cassidy PM, Aggregated antibiograms and monitoring of drug-resistant Streptococcus pneumoniae. Emerg Infect Dis. 2003;9:1089–95.
- Overhage JM, Grannis S, McDonald CJ. A comparison of the completeness and timeliness of automated electronic laboratory reporting and spontaneous reporting of notifiable conditions. Am J Public Health. 2008;98:344–50.
- Centers for Disease Control and Prevention. Automated detection and reporting of notifiable diseases using electronic medical records versus passive surveillance—Massachusetts, June 2006–July 2007. MMWR Morb Mortal Wkly Rep. 2008;57:373–6 .
- Kyaw MH, Rose CE Jr, Fry AM, Singleton JA, Moore Z, Zell ER, The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J Infect Dis. 2005;192:377–86.
- Blain A, MacNeil JR, Wang X, Bennett N, Farley M, Harrison LH, Invasive Haemophilus influenzae disease in adults >65 years, United States, 2011. Open Forum Infect Dis. 2014;1 [cited 2015 Jul 6]. http://ofid.oxfordjournals.org/content/1/2/ofu044.full.pdf+html
- Wortham JM, Gershman K, Baumback J, Farley M, Harrison L, Lynfield R, Racial disparities in invasive pneumococcal disease—United States, 1998–2009 [cited 2015 Jul 8]. Presented at: 61st Annual Epidemic Intelligence Service Conference; 2012 Apr 16–20; Atlanta, GA, USA. http://www.cdc.gov/eis/downloads/2012.eis.conference.pdf.
- Burton DC, Flannery B, Bennett NM, Farley MM, Gershman K, Harrison LH, Socioeconomic and racial/ethnic disparities in the incidence of bacteremic pneumonia among US adults. Am J Public Health. 2010;100:1904–11.
- Soto K, Petit S, Hadler JL. Changing disparities in invasive pneumococcal disease by socioeconomic status and race/ethnicity in Connecticut, 1998–2008. Public Health Rep. 2011;126(Suppl 3):81–8.
Page created: August 12, 2015
Page updated: August 12, 2015
Page reviewed: August 12, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.